Advertisement

Ads Placeholder
IN Stocks

CLEDUCATE.NS plunges 20.66% to INR 58.59 on NSE 09 Feb 2026: volume spike warns momentum may extend

February 9, 2026
4 min read
Share with:

CLEDUCATE.NS stock fell sharply 20.66% to INR 58.59 on the NSE on 09 Feb 2026 as trading closed. The move followed unusually heavy turnover of 357,872.00 shares versus an average daily volume of 30,845.00, pushing relative volume to 11.62. We examine price drivers, valuation, technicals and the outlook for CL Educate Limited (CLEDUCATE.NS) in India’s education sector, and show model-based forecasts and key risks behind the sell-off.

CLEDUCATE.NS stock: intraday price action and volume

The stock declined INR 15.26 or 20.66% from the previous close of INR 73.85. The day range was INR 55.50–61.92 and the session closed at INR 58.59.

Advertisement

Trading volume surged to 357,872.00 shares, roughly 11.62x the average, signalling active selling pressure and possible stop-loss cascades on the NSE.

Valuation and fundamentals driving the sell-off

CL Educate Limited (CLEDUCATE.NS) shows mixed fundamentals, with EPS -1.33 and a negative PE of -44.42, reflecting trailing losses. The company reports cash per share INR 50.33 and book value per share INR 50.46, while market cap stands at INR 3,203,551,439.00.

Debt measures are notable: debt to equity 1.03 and interest coverage 2.40, implying leverage that can amplify downside during weaker revenue or margin pressure in the Education & Training Services industry.

Technical setup and short-term indicators for CLEDUCATE.NS stock

Technicals show a weak near-term bias: RSI 36.88, MACD histogram -0.41, and CCI -154.45 indicating oversold momentum. The 50-day average is INR 80.61 and the 200-day average is INR 90.07, both well above the current price.

On-chain indicators point to lower conviction: ATR is 3.42, and on-balance volume is negative -213,366.00, which confirms distribution through today’s move on the NSE.

Meyka AI grade and model view on CLEDUCATE.NS

Meyka AI rates CLEDUCATE.NS with a score of 69.92 out of 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a 12-month value of INR 98.39, a quarterly projection of INR 36.11, and a monthly read of INR 21.72. These model projections are data-driven and are not guarantees.

Sector context, catalysts and downside risks

CL Educate operates in the Consumer Defensive sector and the Education & Training Services industry. Sector peers show steadier margins and higher PB ratios, making CLEDUCATE.NS relatively cheaper on PB 1.16 but riskier on profitability metrics.

Key near-term catalysts include quarterly results, student enrolment updates, and franchise performance. Primary risks are leverage, weak net margins, and any slowdown in test-prep demand that would pressure revenue and cash flow on the NSE.

Final Thoughts

The sell-off left CLEDUCATE.NS stock trading at INR 58.59 after a 20.66% drop on 09 Feb 2026, driven by heavy volume and negative sentiment. Fundamentals show cash per share INR 50.33 and book value INR 50.46, but earnings remain negative with EPS -1.33 and leverage at debt to equity 1.03. Meyka AI’s forecast model projects a 12-month target of INR 98.39, implying an upside of 67.96% versus the current price. Forecasts are model-based projections and not guarantees. For traders, the combination of oversold technicals and sharp volume suggests continued volatility. For longer-term investors, the case hinges on earnings recovery, margin improvement, and deleveraging. We will watch next quarter’s enrolment numbers and company updates as immediate catalysts on the NSE, and recommend close position sizing until clarity returns.

Advertisement

FAQs

Why did CLEDUCATE.NS stock fall sharply on 09 Feb 2026?

The drop reflects heavy selling with 357,872.00 shares traded, a relative volume of 11.62, and negative sentiment after recent weak earnings and leverage concerns. Technicals looked oversold, amplifying the move on the NSE.

What valuation metrics should investors check for CLEDUCATE.NS stock?

Key metrics include EPS -1.33, PE -44.42, PB 1.16, cash per share INR 50.33, and debt-to-equity 1.03. These measure profitability, balance-sheet strength and downside support.

What does Meyka AI forecast for CLEDUCATE.NS stock?

Meyka AI’s forecast model projects a 12-month level of INR 98.39, a quarterly figure of INR 36.11, and a monthly read of INR 21.72. Forecasts are model-based projections and not guarantees.

Is CLEDUCATE.NS stock a buy after the decline?

The stock shows value traits but remains risky due to negative earnings and leverage. Meyka AI grades it B (HOLD). Investors should wait for clearer improvement in margins or enrolment before adding materially.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Advertisement

Ads Placeholder
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)